The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disease and a common cause of neurological disability in young adults. The modest heritability of MS reflects complex genetic effects and multifaceted gene-environment interactions. The human leukocyte antigen (HLA) region is the strongest susceptibility locus for MS, but a genome-wide association study recently identified new susceptibility genes. Progress in high-throughput genotyping and sequencing technologies and a better understanding of the structural organization of the human genome, together with powerful brain-imaging techniques that refine the phenotype, suggest that the tools could finally exist to identify the full set of genes influencing the pathogenesis of MS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“do not seem to have a significant genetic component”
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439 · cited 1×
“It is of considerable interest that a recent clinical trial of an anti-B-cell therapy in MS showed marked effects in reducing bursts of focal inflammatory disease activity, establishing the vital importance of B cells as triggers of MS attack”
BackgroundSelf-citationWacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., & Rothman, N. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh075 · Cited by 1,754
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669 · cited 1×
“Low- and high-capacity microarray studies of the MS brain lesion have been publishe”
BackgroundSelf-citationGenetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
Linkage strategies for genetically complex traits. I. Multilocus models.
RISCH, N. J. (1990) · PubMed · Cited by 1,309
Genome-wide association studies: theoretical and practical concerns
Wang, W. Y. S., Barratt, B. J., Clayton, D. G., & Todd, J. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1522 · Cited by 1,165
Population genomics of human gene expression
Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A., Bird, C. P., Beazley, C., Ingle, C. E., Dunning, M., Flicek, P., Koller, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2142 · Cited by 1,157 · cited 1×
“Whether the observed changes are causal or reactive to the disease process remains unknown, but the analysis of genomically controlled differential gene expression might prove to be an effective tool to isolate primary disease gene”
MethodInterferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154 · cited 1×
“Current MS therapies are all immunomodulatory; that is, they partially protect against relapses but are ineffective against purely progressive symptom”
BackgroundEnvironmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042 · cited 1×
“Migration studies and reports of clusters and outbreaks have been influential if inconclusive, and together they support a strong role for environmental factors in MS as well as the existence of crucial time periods (probably occurring between 5 and 15 years of age) for exposure to the putative environmental trigger”
BackgroundSex ratio of multiple sclerosis in Canada: a longitudinal study
Orton, S.-M., Herrera, B. M., Yee, I. M., Valdar, W., Ramagopalan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70581-6 · Cited by 921
Variation is the spice of life
Kruglyak, L., & Nickerson, D. A. (2001) · Nature Genetics · doi:10.1038/85776 · Cited by 910
Natural history of multiple sclerosis: a unifying concept
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awl007 · Cited by 905
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 841 · cited 1×
“Low- and high-capacity microarray studies of the MS brain lesion have been publishe”
BackgroundThe Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776 · cited 1×
“Contemporary models of pathogenesis support the occurrence of two overlapping and connected effector arms — inflammatory and neurodegenerativ”
BackgroundSelf-citationDysregulated Epstein-Barr virus infection in the multiple sclerosis brain
Serafini, B., Rosicarelli, B., Franciotta, D., Magliozzi, R., Reynolds, R., Cinque, P., Andreoni, L., Trivedi, P., Salvetti, M., Faggioni, A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071030 · Cited by 766
Chesler, E. J., Lu, L., Shou, S., Qu, Y., Gu, J., Wang, J., Hsu, H. C., Mountz, J. D., Baldwin, N. E., Langston, M. A., et al. (2005) · Nature Genetics · doi:10.1038/ng1518 · Cited by 719 · cited 1×
“Whether the observed changes are causal or reactive to the disease process remains unknown, but the analysis of genomically controlled differential gene expression might prove to be an effective tool to isolate primary disease gene”
MethodEnvironmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714
for the Multiple Sclerosis Genetics Group, Gregory, S. G., Schmidt, S., Seth, P., Oksenberg, J. R., Hart, J., Prokop, A., Caillier, S. J., Ban, M., Goris, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2103 · Cited by 657
Self-citationThe prevalence of multiple sclerosis in the world: an update
Rosati, G. (2001) · Neurological Sciences · doi:10.1007/s100720170011 · Cited by 656
Interleukin-7 receptor expression: intelligent design
Mazzucchelli, R., & Durum, S. K. (2007) · Nature Reviews Immunology · doi:10.1038/nri2023 · Cited by 652 · cited 1×
“IL7R-mediated signalling is essential for the development and survival of T lymphocyte”
BackgroundA genetic basis for familial aggregation in multiple sclerosis
Ebers, G. C., Sadovnick, A. D., & Risch, N. J. (1995) · Nature · doi:10.1038/377150a0 · Cited by 615
Genetic associations in large versus small studies: an empirical assessment
Ioannidis, J. P., Trikalinos, T. A., Ntzani, E. E., & Contopoulos-Ioannidis, D. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12516-0 · Cited by 579
Natural variation in human gene expression assessed in lymphoblastoid cells
Cheung, V. G., Conlin, L. K., Weber, T. M., Arcaro, M., Jen, K.-Y., Morley, M., & Spielman, R. S. (2003) · Nature Genetics · doi:10.1038/ng1094 · Cited by 550 · cited 1×
“Whether the observed changes are causal or reactive to the disease process remains unknown, but the analysis of genomically controlled differential gene expression might prove to be an effective tool to isolate primary disease gene”
MethodEpstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Ascherio, A., Munger, K. L., Lennette, E. T., Spiegelman, D., Hernán, M. A., Olek, M. J., Hankinson, S. E., & Hunter, D. J. (2001) · JAMA · doi:10.1001/jama.286.24.3083 · Cited by 549
Twin concordance and sibling recurrence rates in multiple sclerosis
Willer, C. J., Dyment, D. A., Risch, N. J., Sadovnick, A. D., Ebers, G. C., & The Canadian Collaborative Study Group§§ (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1932604100 · Cited by 532
HLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
Olerup, O., & Hillert, J. (1991) · Tissue Antigens · doi:10.1111/j.1399-0039.1991.tb02029.x · Cited by 490
Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis
Lundmark, F., Duvefelt, K., Iacobaeus, E., Kockum, I., Wallström, E., Khademi, M., Oturai, A., Ryder, L. P., Saarela, J., Harbo, H. F., et al. (2007) · Nature Genetics · doi:10.1038/ng2106 · Cited by 483
Steinman, L., & Zamvil, S. S. (2006) · Annals of Neurology · doi:10.1002/ana.20913 · Cited by 479
Methods for High-Density Admixture Mapping of Disease Genes
Patterson, N., Hattangadi, N., Lane, B., Lohmueller, K. E., Hafler, D. A., Oksenberg, J. R., Hauser, S. L., Smith, M. W., O’Brien, S. J., Altshuler, D., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/420871 · Cited by 478 · cited 1×
“Because the sections of the genome in African Americans that is inherited from their European or African ancestors have only had an average of six generations of recombination, extended LD is present in these segments and disease genes are potentially amenable to identification through admixture mapping”
BackgroundSelf-citationTiming of birth and risk of multiple sclerosis: population based study
Willer, C. J., Dyment, D. A., Sadovnick, A. D., Rothwell, P. M., Murray, T. J., & Ebers, G. C. (2005) · BMJ · doi:10.1136/bmj.38301.686030.63 · Cited by 451
Levin, L. I. (2005) · JAMA · doi:10.1001/jama.293.20.2496 · Cited by 448
The worldwide prevalence of multiple sclerosis
Pugliatti, M., Sotgiu, S., & Rosati, G. (2002) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00036-7 · Cited by 370
Evidence for genetic basis of multiple sclerosis
Sadovnick, A. D., the Canadian Collaborative Study Group, Dyment, D. A., Ebers, G. C., & Risch, N. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90807-7 · Cited by 351
Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans
Oksenberg, J. R., Barcellos, L. F., Cree, B. A. C., Baranzini, S. E., Bugawan, T. L., Khan, O., Lincoln, R. R., Swerdlin, A., Mignot, E., Lin, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380997 · Cited by 340 · cited 1×
“In a study of HLA-DRB1 and HLA-DQB1 alleles and haplotypes in an African-American MS cohort, a selective association with HLA-DRB1 independent of HLA-DQB1 was reveale”
BackgroundSelf-citationLincoln, M. R., Montpetit, A., Cader, M. Z., Saarela, J., Dyment, D. A., Tiislar, M., Ferretti, V., Tienari, P. J., Sadovnick, A. D., Peltonen, L., et al. (2005) · Nature Genetics · doi:10.1038/ng1647 · Cited by 332
Cepok, S., Zhou, D., Srivastava, R., Nessler, S., Stei, S., Büssow, K., Sommer, N., & Hemmer, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523661 · Cited by 323
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
Barcellos, L. F., Sawcer, S., Ramsay, P. P., Baranzini, S. E., Thomson, G., Briggs, F., Cree, B. C. A., Begovich, A. B., Villoslada, P., Montalban, X., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl223 · Cited by 317 · cited 1×
“The association with this locus was observed across virtually all populations, and in both primary progressive and relapsing–remitting patients, suggesting that HLA -related mechanisms are contributing to both phenotype”
BackgroundSelf-citationThe British Isles survey of multiple sclerosis in twins
Mumford, C. J., Wood, N. W., Kellar-Wood, H., Thorpe, J. W., Miller, D. H., & Compston, D. A. S. (1994) · Neurology · doi:10.1212/wnl.44.1.11 · Cited by 311
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
Cree, B. A. C., Khan, O., Bourdette, D., Goodin, D. S., Cohen, J. A., Marrie, R. A., Glidden, D., Weinstock-Guttman, B., Reich, D., Patterson, N., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145762.60562.5d · Cited by 301
Self-citationA High-Density Screen for Linkage in Multiple Sclerosis
(2005) · The American Journal of Human Genetics · doi:10.1086/444547 · Cited by 297
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
Smith, K. J., Pyrdol, J., Gauthier, L., Wiley, D. C., & Wucherpfennig, K. W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1511 · Cited by 294 · cited 1×
“HLA-DRB1 a 1501, for example, is different from other HLA-DRB molecules owing to the large hydrophobic P4 pocket, which favours the binding of aromatic residues in the ligan”
BackgroundHLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R. R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Self-citationHaines, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1229 · Cited by 284
A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility
Reich, D., Patterson, N., Jager, P. L. D., McDonald, G. J., Waliszewska, A., Tandon, A., Lincoln, R. R., DeLoa, C., Fruhan, S. A., Cabre, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1646 · Cited by 271 · cited 1×
“At the peak, European ancestry rises from the genome-wide average of 21% to a maximum of 27%, suggesting the presence of a susceptibility gene or genes in this regio”
BackgroundSelf-citationParent-of-origin effect in multiple sclerosis: observations in half-siblings
Ebers, G., Sadovnick, A., Dyment, D., Yee, I., Willer, C., & Risch, N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16304-6 · Cited by 269
Miretti, M. M., Walsh, E. C., Ke, X., Delgado, M., Griffiths, M., Hunt, S., Morrison, J., Whittaker, P., Lander, E. S., Cardon, L. R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429393 · Cited by 256 · cited 1×
“However, the identification of the true predisposing gene or genes within the extended susceptibility haplotype has been handicapped by the remarkably strong linkage disequilibrium (LD) across the MHC regio”
BackgroundComplex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance
Dyment, D. A., Herrera, B. M., Cader, M. Z., Willer, C. J., Lincoln, M. R., Sadovnick, A. D., Risch, N., & Ebers, G. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi206 · Cited by 252 · cited 1×
“1 ), suggesting a disease association gradient ranging from high vulnerability ( HLA-DRB1 a 15 homozygotes and HLA-DRB1 a 15/HLA-DRB1 a 08 heterozygotes) to low susceptibility or resistance ( HLA-DRB1 a 15/HLA-DRB1 a 14 heterozygotes”
BackgroundIoannidis, J. P. A., Trikalinos, T. A., & Khoury, M. J. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj259 · Cited by 246 · cited 1×
“Second, the significant amount of genetic variation in the human population means that relevant signals have to be sorted from an overwhelming amount of nois”
BackgroundAge–adjusted recurrence risks for relatives of patients with multiple sclerosis
Robertson, N. P., Fraser, M., Deans, J., Clayton, D., Walker, N., & Compston, D. A. S. (1996) · Brain · doi:10.1093/brain/119.2.449 · Cited by 234
Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins
Islam, T., Gauderman, W. J., Cozen, W., & Mack, T. M. (2007) · Neurology · doi:10.1212/01.wnl.0000268266.50850.48 · Cited by 232
Wallin, M. T., Page, W. F., & Kurtzke, J. F. (2004) · Annals of Neurology · doi:10.1002/ana.10788 · Cited by 224 · cited 1×
“African Americans are at a lower risk for MS when compared with northern Europeans and white American”
BackgroundBomprezzi, R., Ringnér, M., Kim, S., Bittner, M. L., Khan, J., Chen, Y., Elkahloun, A., Yu, A., Bielekova, B., Meltzer, P. S., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg221 · Cited by 213
Functional epistasis on a common MHC haplotype associated with multiple sclerosis
Gregersen, J. W., Kranc, K. R., Ke, X., Svendsen, P., Madsen, L. S., Thomsen, A. R., Cardon, L. R., Bell, J. I., & Fugger, L. (2006) · Nature · doi:10.1038/nature05133 · Cited by 205
How many genes underlie the occurrence of common complex diseases in the population?
Yang, Q., Khoury, M. J., Friedman, J., Little, J., & Flanders, W. D. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi130 · Cited by 184
Sundvall, M., Jirholt, J., Yang, H.-T., Jansson, L., Engström, Å., Pettersson, U., & Holmdahl, R. (1995) · Nature Genetics · doi:10.1038/ng0795-313 · Cited by 180
A second major histocompatibility complex susceptibility locus for multiple sclerosis
Yeo, T. W., De Jager, P. L., Gregory, S. G., Barcellos, L. F., Walton, A., Goris, A., Fenoglio, C., Ban, M., Taylor, C. J., Goodman, R. S., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21063 · Cited by 175
Self-citationByun, E., Caillier, S. J., Montalban, X., Villoslada, P., Fernández, O., Brassat, D., Comabella, M., Wang, J., Barcellos, L. F., Baranzini, S. E., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2008.47 · Cited by 174 · cited 1×
“Furthermore, given the significant variation in response to currently available treatments, genome-wide pharmacogenomics studies will directly address the question of genetic heterogeneity in MS by analysis of the correlation between different genotypes and the clinical response to therap”
BackgroundSelf-citationTranscription-Based Prediction of Response to IFNβ Using Supervised Computational Methods
Baranzini, S. E., Mousavi, P., Rio, J., Caillier, S. J., Stillman, A., Villoslada, P., Wyatt, M. M., Comabella, M., Greller, L. D., Somogyi, R., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0030002 · Cited by 169
Self-citationFreedman, D. M., Dosemeci, M., & Alavanja, M. C. R. (2000) · Occupational and Environmental Medicine · doi:10.1136/oem.57.6.418 · Cited by 168
Genetic basis for clinical expression in multiple sclerosis
The Multiple Sclerosis Genetics Group, Barcellos, L. F., Oksenberg, J. R., Green, A. J., Bucher, P., Rimmler, J. B., Schmidt, S., Garcia, M. E., Lincoln, R. R., Pericak‐Vance, M. A., et al. (2002) · Brain · doi:10.1093/brain/awf009 · Cited by 156
Self-citationMarrosu, M. G. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2907 · Cited by 155
Zhang, Z., Duvefelt, K., Svensson, F., Masterman, T., Jonasdottir, G., Salter, H., Emahazion, T., Hellgren, D., Falk, G., Olsson, T. P., et al. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364171 · Cited by 154
Concordance for multiple sclerosis in Danish twins: an update of a nationwide study
Hansen, T., Skytthe, A., Stenager, E., Petersen, H. C., Brønnum-Hansen, H., & Kyvik, K. O. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1220oa · Cited by 143
Mechanism of Action of Glatiramer Acetate in Treatment of Multiple Sclerosis
Weber, M. S., Hohlfeld, R., & Zamvil, S. S. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.08.002 · Cited by 139
DeLuca, G. C., Ramagopalan, S. V., Herrera, B. M., Dyment, D. A., Lincoln, M. R., Montpetit, A., Pugliatti, M., Barnardo, M. C. N., Risch, N. J., Sadovnick, A. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707731105 · Cited by 137
Satoh, J., Nakanishi, M., Koike, F., Miyake, S., Yamamoto, T., Kawai, M., Kikuchi, S., Nomura, K., Yokoyama, K., Ota, K., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.007 · Cited by 135
The Inheritance of Resistance Alleles in Multiple Sclerosis
Ramagopalan, S. V., Morris, A. P., Dyment, D. A., Herrera, B. M., DeLuca, G. C., Lincoln, M. R., Orton, S. M., Chao, M. J., Sadovnick, A. D., & Ebers, G. C. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030150 · Cited by 132 · cited 1×
“1 ), suggesting a disease association gradient ranging from high vulnerability ( HLA-DRB1 a 15 homozygotes and HLA-DRB1 a 15/HLA-DRB1 a 08 heterozygotes) to low susceptibility or resistance ( HLA-DRB1 a 15/HLA-DRB1 a 14 heterozygotes”
BackgroundB-LYMPHOCYTE ALLOANTIGENS ASSOCIATED WITH MULTIPLE SCLEROSIS
Compston, D. A. S. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92027-4 · Cited by 128
Lindberg, R. L. P., Groot, C. J. A. D., Certa, U., Ravid, R., Hoffmann, F., Kappos, L., & Leppert, D. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.03.011 · Cited by 111 · cited 1×
“Low- and high-capacity microarray studies of the MS brain lesion have been publishe”
BackgroundRisks of multiple sclerosis in relatives of patients in Flanders, Belgium.
Carton, H., Vlietinck, R., Debruyne, J., De Keyser, J., D'Hooghe, M. B., Loos, R., Medaer, R., Truyen, L., Yee, I. M., & Sadovnick, A. D. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.4.329 · Cited by 110
Ramanathan, M. K., Weinstock‐Guttman, B., Nguyen, L. T., Badgett, D., Miller, C., Patrick, K., Brownscheidle, C. M., & Jacobs, L. R. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00308-3 · Cited by 108
Differential twin concordance for multiple sclerosis by latitude of birthplace
Islam, T., Gauderman, W. J., Cozen, W., Hamilton, A. S., Burnett, M. E., & Mack, T. M. (2006) · Annals of Neurology · doi:10.1002/ana.20871 · Cited by 106
Thrombolysis in Patients With Acute Stroke Caused by Cervical Artery Dissection
Arnold, M., Nedeltchev, K., Sturzenegger, M., Schroth, G., Loher, T. J., Stepper, F., Remonda, L., Bassetti, C. L., & Mattle, H. P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.4.549 · Cited by 105
Evidence that the Y chromosome influences autoimmune disease in male and female mice
Teuscher, C., Noubade, R., Spach, K., McElvany, B., Bunn, J. Y., Fillmore, P. D., Zachary, J. F., & Blankenhorn, E. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600536103 · Cited by 100
Rubio, J. P., Bahlo, M., Butzkueven, H., van der Mei, I. A. F., Sale, M. M., Dickinson, J. L., Groom, P., Johnson, L., Simmons, R. D., Tait, B. D., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339932 · Cited by 98
Teutsch, S. M., Booth, D. R., Bennetts, B., Heard, R. N., & Stewart, G. J. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200994 · Cited by 98
Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity
Stratmann, T., Martin-Orozco, N., Mallet-Designe, V., Poirot, L., McGavern, D., Losyev, G., Dobbs, C. M., Oldstone, M. B. A., Yoshida, K., Kikutani, H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18337 · Cited by 96 · cited 1×
“The most plausible explanation assumes that the effect is mediated by the traditional physiological functions of HLA molecules in immune responses, including antigen binding and presentation, and by T-cell repertoire determination by negative selection of high-avidity autoreactive T cells in the embry”
BackgroundFamilial effects on the clinical course of multiple sclerosis
Hensiek, A. E., Seaman, S. R., Barcellos, L. F., Oturai, A., Eraksoi, M., Cocco, E., Vecsei, L., Stewart, G., Dubois, B., Bellman-Strobl, J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000252822.53506.46 · Cited by 90
Self-citationFamilial factors influence disability in MS multiplex families
Brassat, D., Azais-Vuillemin, C., Yaouanq, J., Semana, G., Reboul, J., Cournu, I., Mertens, C., Edan, G., Lyon-Caen, O., Clanet, M., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1632 · Cited by 84
HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype
Prat, E., Tomaru, U., Sabater, L., Park, D. M., Granger, R., Kruse, N., Ohayon, J. M., Bettinotti, M. P., & Martinꝉ, R. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.027 · Cited by 82
Blankenhorn, E. P., Butterfield, R. J., Rigby, R., Cort, L., Giambrone, D., McDermott, P., McEntee, K., Solowski, N., Meeker, N. D., Zachary, J. F., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3420 · Cited by 77
McDonnell, G. V., Mawhinney, H., Graham, C. A., Hawkins, S. A., & Middleton, D. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00084-2 · Cited by 77
McKay, F. C., Swain, L. I., Schibeci, S. D., Rubio, J. P., Kilpatrick, T. J., Heard, R. N., Stewart, G. J., & Booth, D. R. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364436 · Cited by 72
Genomics in multiple sclerosis—Current state and future directions
Comabella, M., & Martinꝉ, R. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.02.009 · Cited by 72 · cited 1×
“(for more detailed summaries of microarray studies in MS, see Ref”
BackgroundToward the development of rational therapies in multiple sclerosis: what is on the horizon?
Hemmer, B., & Hartung, H. (2007) · Annals of Neurology · doi:10.1002/ana.21289 · Cited by 70 · cited 1×
“Current MS therapies are all immunomodulatory; that is, they partially protect against relapses but are ineffective against purely progressive symptom”
BackgroundAchiron, A., Feldman, A., Mandel, M., & Gurevich, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1381.017 · Cited by 66
Teuscher, C., Bunn, J. Y., Fillmore, P. D., Butterfield, R. J., Zachary, J. F., & Blankenhorn, E. P. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63416-5 · Cited by 65
Genomewide Study of Multiple Sclerosis
Ramagopalan, S. V., Anderson, C. A., Sadovnick, A. D., & Ebers, G. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmc072836 · Cited by 61
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region
de Jong, B. A., Huizinga, T. W. J., Zanelli, E. H., Giphart, M. J., Bollen, E. L. E. M., Uitdehaag, B. M. J., Polman, C. H., & Westendorp, R. G. J. (2002) · Neurology · doi:10.1212/wnl.59.4.549 · Cited by 61
DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain
Fern�ndez, O., Fern�ndez, V., Alonso, A., Caballero, A., Luque, G., Bravo, M. J., Le�n, A., Mayorga, C., Leyva, L., & de Ram�n, E. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0350-2 · Cited by 57
McElroy, J., & Oksenberg, J. R. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-73677-6_3 · Cited by 55
Self-citationA specific viral cause of multiple sclerosis: One virus, one disease
Lipton, H. L., Liang, Z., Hertzler, S., & Son, K. (2007) · Annals of Neurology · doi:10.1002/ana.21116 · Cited by 53
Sospedra, M., Muraro, P. A., Štefanová, I., Zhao, Y., Chung, K., Li, Y., Giulianotti, M. A., Simon, R. M., Mariuzza, R. A., Pinilla, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1951 · Cited by 53
Baranzini, S. E., Bernard, C. C. A., & Oksenberg, J. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7412 · Cited by 45
Self-citationSeldin, M. F., Morii, T., Collins-Schramm, H. E., Chima, B., Kittles, R. A., Criswell, L. A., & Li, H. (2004) · Genome Research · doi:10.1101/gr.2165904 · Cited by 44 · cited 1×
“Because the sections of the genome in African Americans that is inherited from their European or African ancestors have only had an average of six generations of recombination, extended LD is present in these segments and disease genes are potentially amenable to identification through admixture mapping”
BackgroundFernald, G. H., Yeh, R., Hauser, S. L., Oksenberg, J. R., & Baranzini, S. E. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.032 · Cited by 42
Self-citationSotgiu, S., Maura, P., Alessandra, S., Sanna, A., & Giulio, R. (2003) · Autoimmunity · doi:10.1080/0891693031000151607 · Cited by 38
Khare, M., Mangalam, A. K., Rodriguez, M., & David, C. S. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.023 · Cited by 37
The genetics of multiple sclerosis and its experimental models
Olsson, T. P., & Hillert, J. A. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282fd10cc · Cited by 36
Familial recurrence risks and inheritance of multiple sclerosis.
Sadovnick, A. D. (1993) · PubMed · Cited by 34
Patterns of disease in concordant parent–child pairs with multiple sclerosis
Hupperts, R., Broadley, S., Mander, A., Clayton, D. G., Compston, D. A. S., & Robertson, N. P. (2001) · Neurology · doi:10.1212/wnl.57.2.290 · Cited by 33
Genetically Dominant Spinal Cord Repair in a Murine Model of Chronic Progressive Multiple Sclerosis
Bieber, A. J., Ure, D. R., & Rodriguez, M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.1.46 · Cited by 33
Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele
Fukazawa, T., Kikuchi, S., Sasaki, H., Yabe, I., Miyagishi, R., Hamada, T., & Tashiro, K. (2000) · Journal of Neurology · doi:10.1007/s004150050558 · Cited by 32
Mangalam, A. K., Luckey, D. H., Basal, E., Behrens, M. D., Rodriguez, M., & David, C. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7747 · Cited by 26
Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis
Rasmussen, H. B., Kelly, M. A., & Clausen, J. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700203 · Cited by 23
Otaegui, D., Mostafavi, S., Bernard, C., de Munain, A. L., Mousavi, P., Oksenberg, J., & Baranzini, S. (2007) · Journal of Immunology · doi:10.4049/jimmunol.179.6.4074 · Cited by 23
Self-citationWucherpfennig, K. W. (2006) · Springer eBooks · doi:10.1007/3-540-30791-5_2 · Cited by 22
Baranzini, S. E. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:031 · Cited by 22
Self-citationThe developing mosaic of autoimmune disease risk
Maier, L. M., & Hafler, D. A. (2008) · Nature Genetics · doi:10.1038/ng0208-131 · Cited by 17 · cited 1×
“Interestingly, the IL2RA -mediated susceptibility effect is shared among MS, type 1 diabetes, Graves disease and rheumatoid arthritis, suggesting that common disease mechanisms underlie different autoimmune condition”
BackgroundSchmidt, S., Pericak‐Vance, M. A., Sawcer, S. J., Barcellos, L. F., Hart, J., Sims, J., Prokop, A. M., van der Walt, J., DeLoa, C., Lincoln, R., et al. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364311 · Cited by 17
Self-citationCurrent State and Future Directions
(2009) · CRC Press eBooks · doi:10.1201/9781420062236-c9 · Cited by 15
(2000) · doi:10.1002/1531-8249(200012)48:6
Research works printed but not linked: 3
- Hauser, S. L. & Goodin, D. S. in Harrison's Principle of Internal Medicine 17th edn (eds Fauci, A. D. et al.) 2611–2620 (McGraw Hill, New York, 2008).
- Kantarci, O. H. et al. Men with MS transmit the disease more often to their children then women: the Carter effect. Mult. Scler. 10, S203 (2004).
- Anderson, A. & Karlsson J. Genetic of experimental autoimmune encephalomyelitis in the mouse. Arch. Immunol. Ther. Exp. (Warz) 52, 316–325 (2004).
Cited by
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
Common variants on chromosome 6p22.1 are associated with schizophrenia
Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe’er, I., Dudbridge, F., Holmans, P. A., Whittemore, A. S., Mowry, B. J., et al. (2009) · Nature · doi:10.1038/nature08192 · Cited by 1,170
Self-citationThe HLA genomic loci map: expression, interaction, diversity and disease
Shiina, T., Hosomichi, K., Inoko, H., & Kulski, J. K. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.5 · Cited by 782
Kappos, L., Li, D., Calabresi, P. A., O'Connor, P., Bar-Or, A., Barkhof, F., Yin, M., Leppert, D., Glanzman, R., Tinbergen, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61649-8 · Cited by 743
Self-citation
Metadata
- Authors
- Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L.
- Affiliations
- University of California, San Francisco (US)
- University of Cambridge (GB)
- Corresponding author
- Oksenberg, Jorge R.
- Hauser, Stephen L.
- Venue
- Nature Reviews Genetics
- Published
- 2008-06-10
- Volume
- 9
- Issue
- 7
- Pages
- 516-526
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W1991500494
- Cited by
- 347
- References
- 125
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 7 · 2018: 10 · 2017: 15 · 2016: 15 · 2015: 22 · 2014: 27 · 2013: 20 · 2012: 22
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, single nucleotide polymorphisms, genome-wide association study, HLA region, gene-environment interaction, autoimmune demyelinating disease, pathogenesis, susceptibility genes, neuroimaging
- MeSH terms
- Animals, HLA Antigens, Humans, Multiple Sclerosis, Genome, Human, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.